Intraocular Injection Guide

An intraocular injection device, comprising:

• (a) an elongated tubular member having an injector receiving end and a scleral end, with the scleral end further comprising an end flange disposed at the corneal end;
• (b) a lumen extending from an injector receiving end to the end flange, the lumen having a lower lumenal end and a lower lumenal end, the lower lumenal end further having a syringe stopper, the syringe stopper is adapted to control the depth of a needle penetration into an eyeball;
• (c) the end flange being disposed around three sides of the corneal end, the end flange also including a scleral surface disposed on one side of the end flange;
• (d) the scleral surface is curved to match the corneal or scleral surface of an eyeball, the surface further having a corneal edge that is adapted to align to a cornea of the eyeball;
• and
• (e) the end flange further including a needle exit, the needle exit having a needle exit corneal edge that is no less than 3 mm from the flange corneal edge;
• (f) the end flange also including at least one end flange surfaces adapted to permit an eyelid to smoothly travel over the at least one end flange surface.

An intraocular injection device kit, the kit comprising:

• (a) an elongated tubular member having an injector receiving end and a scleral end, with the scleral end further comprising an end flange disposed at the corneal end;
• (b) a lumen extending from an injector receiving end to the end flange, the lumen having a lower lumenal end and a lower lumenal end, the lower lumenal end further having a syringe stopper, the syringe stopper is adapted to control the depth of a needle penetration into an eyeball;
• (c) the end flange being disposed around three sides of the corneal end, the end flange also including a scleral surface disposed on one side of the end flange;
• (d) the scleral surface is curved to match the corneal or scleral surface of an eyeball, the surface further having a corneal edge that is adapted to align to a cornea of the eyeball;
• (e) the end flange further including a needle exit, the needle exit having a needle exit corneal edge that is no less than 3 mm from the flange corneal edge;
• and
• (f) a medicine either in a vial or in a prefilled syringe, the medicine comprising at least one of an anti-VEGF, a prostaglandin, a rapamycin or derivative thereof, an antiretroviral, a peptide or polypeptide, a steroid, a NSAID, a carbonic anhydrase inhibitor, a beta-andrenergic receptor antagonist, and an immunosuppressant;
• or combination thereof.